Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 7, 2005, Pages 1253-1256

  Doggrell, Sheila A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Aspirin; Clinical trial; Clopidogrel; Esomeprazole; Recurrent ulcer bleeding

Indexed keywords

ACETYLSALICYLIC ACID; BENATOPRAZOLE; CLOPIDOGREL; ENALAPRIL; ESOMEPRAZOLE; HYDROCHLOROTHIAZIDE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL TRIAL; DIGESTIVE SYSTEM ULCER; DRUG CHOICE; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG TOLERABILITY; DUODENUM ULCER; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMATURIA; HUMAN; HYPERTENSION; LONG TERM CARE; LOW DRUG DOSE; SECONDARY PREVENTION; STOMACH ULCER; STROKE; ULCER HEALING;

EID: 21844461843     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.7.1253     Document Type: Article

References (9)

1. CHAN FK, CHING MP, HUNG LC et al.: Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N. Engl. J. Med. (2005) 352:238-244.
2. CAPRIE STEERING COMMITTEE: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet (1996) 348:1329-1339.
3. GASPOZ JM, COXDON PG, GOLDMAN PA et al.: Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N. Engl. J. Med. (2002) 346:1800-1806.
4. DERRY S, LOKE YK: Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. Br. Med. J. (2000) 321:1183-1187.
5. LAI KC, LAM SK, CHU KM et al.: Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N. Engl. J. Med. (2002) 346:2033-2038.
6. RAGHUNATH AS, GREEN JR, EDWARDS SJ: A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis. Clin. Ther. (2003) 25:2088-2101.
7. NG FH, WONG SY, CHANG CM et al.: High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment. Pharmacol. Ther. (2003) 18:443-449.
8. KATZ PO: Effectiveness of proton pump inhibitors: beyond cost. Rev. Gastroenterol. Disord. (2004) 4(Suppl. 4):S8-S15.
9. GALMICHE JP, SACHER-HUVELIN S, BRULEY DES VARANNES S et al.: A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers.